World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00433316
Date of registration: 08/02/2007
Primary sponsor: Carmel Medical Center
Public title: Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy
Scientific title: Pain Relief by Continuous Intra-Peritoneal Nebulization of Ropivacaine During Gynecological Laparoscopic Surgery
Date of first enrolment: February 2007
Target sample size: 40
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00433316
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment  
Countries of recruitment
Israel
Contacts
Name:   Reuven Pizov, Prof.
Address: 
Telephone:
Email:
Affiliation:  Carmel Medical Center, Haifa, Israel
Name:   Yuval Kaufman, MD
Address: 
Telephone:
Email:
Affiliation:  Carmel Medical Center, Haifa, Israel
Key inclusion & exclusion criteria

Inclusion Criteria:

- Elective gynecologic laparoscopic surgery including unilateral or bilateral
salpingo-oopherectomy or ovarian cystectomy.

- The patient is not participating in other medical study at present or in the last 30
days.

- The patient signed on an informed consent.

- Age 18 years and above.

- ASA (American Society of Anesthesiologists) physical status grade 1- 2.

Exclusion Criteria:

- Allergy to Ropivacaine, other local anesthetics or other medications listed in the
protocol.

- The patient is participating in other medical experiment at present or in the last 30
days.

- Acute Pelvic Inflammatory Disease.

- Coumadin or Aspirin treatment.

- ASA physical status grade 3-4.

- Age < 18 years.

- Significant arrythmias

- Analgesic treatment for chronic pain



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Laparoscopic Surgical Procedures
Intervention(s)
Device: Aeroneb Pro Nezulizer, Aerogen, Ireland
Drug: ropivacaine
Primary Outcome(s)
VAS score [Time Frame: early post-operative]
Secondary Outcome(s)
Secondary ID(s)
CMC064113CTIL
HT 3758
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history